Skip to content

KMTS KMTS Investing Cash Flow

Investing Cash Flow at other companies

Abbott logo
AbbottABT
-$20.32B-4,224%
Boston Scientific logo
Boston ScientificBSX
-$591M-18.2%
Medtronic logo
MedtronicMDT
-$917M-87.1%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$30.22M+179%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$7.73M+126%
Haemonetics logo
HaemoneticsHAE
-$86.61M

Other financials

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
Net income-$34.2M-58.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M
Total assets$379.3M

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation

See full
Market cap$1.29B+70.8%
Enterprise value$1.04B
P/S15.4×

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's investing cash flow?
KMTS (KMTS) reported investing cash flow of -$14.92M in Q4 2025.
How has KMTS's investing cash flow changed year-over-year?
KMTS's investing cash flow decreased by 235.3% year-over-year, from -$4.45M to -$14.92M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.